MS CLINICAL RESEARCH
MS Clinical Research is a Bangalore-headquartered, full-service clinical and preclinical contract research organization providing GLP-compliant dermatology, ophthalmology, and consumer product testing to pharmaceutical, cosmetics, and consumer goods companies across global markets.
- Company typePrivate
- Founded2009
- HeadquartersBangalore, India
- Headcount101–250
- GTM typeB2B
- OfferingServices
What MS CLINICAL RESEARCH does
MS Clinical Research (MSCR) is a Bangalore-headquartered, full-service clinical and preclinical contract research organization founded in 2009. The company runs a 360-degree testing platform spanning dermatology and ophthalmology clinical trials (Phases II-IV), GLP-compliant preclinical studies (in vitro toxicology, microbiology, ex vivo, stability), and consumer product testing across skin, hair, oral, home, colour cosmetics, baby care, and SPF categories. MSCR holds ISO 9001:2015, GLP, and NABL (ISO/IEC 17025:2017) accreditations, maintains an active subject database of 11,000+ individuals with documented expertise in skin-of-colour evaluation, and operates India's only photobiology testing centre for SPF/UVAPF work using Solar Light simulators. It also runs a dedicated gene sequencing lab (launched 2024) equipped with Illumina Nextseq1000 for dermatogenomics and microbiome analysis.
The company is privately held by the Sachdev family — Rohit Sachdev serves as Managing Director and Dr. Mukta Sachdev as Medical Director, with second-generation leadership in business development and operations. MSCR delivers services through three Bangalore facilities totaling 15,000+ sq ft, a US sales/marketing subsidiary in New Jersey, and a European operations subsidiary in Bratislava, supported by a 40+ site global clinical trial network spanning 16 countries. The business model is project-based professional services revenue from pharmaceutical, cosmetics, and consumer products companies, with proprietary in-house tools (eCRF/EDC software and a Compliance App) that support study execution. There are no disclosed external funding rounds, and operating capacity is described at 300+ studies per year for 190+ customers with a targeted 10-day turnaround on high-performance data delivery.
MS CLINICAL RESEARCH firmographics
Firmographics- Name
- MS CLINICAL RESEARCH
- Legal name
- MS Clinical Research Private Limited
- Website
- https://msclinical.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- MS Clinical Research is a Bangalore-headquartered, full-service clinical and preclinical contract research organization providing GLP-compliant dermatology, ophthalmology, and consumer product testing to pharmaceutical, cosmetics, and consumer goods companies across global markets.
- Ownership category
- akta.pro rank
MS CLINICAL RESEARCH industry classification
Industry- Product category
- Contract Research Organization (Clinical and Preclinical Research Services)
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)
- akta.pro secondary industries
- GLP Toxicology (Repeat-Dose, Acute/Subacute) (HLAGAFAD), Nonclinical Study Management & Regulatory Writing (IND-enabling) (HLAGAFAN), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)
Keywords
Where MS CLINICAL RESEARCH is headquartered
LocationHeadquarters
- HQ city
- Bangalore
- HQ country
- India
- HQ region
- Asia
Offices3 records
Markets served
MS CLINICAL RESEARCH business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others
Revenue model
- Clinical Trials Services: Phase II, III, and IV clinical trials across dermatology and ophthalmology for pharmaceutical and cosmetics companies, including FDA studies
- Preclinical Testing Services: GLP-compliant preclinical studies including in vitro toxicology, microbiology, efficacy testing, and stability testing using reconstructed tissue models
- Safety Testing Services: Comprehensive safety assessment including HRIPT, patch tests, ocular irritation tests, and cumulative irritation tests
- Claim Substantiation Studies: R&D services to support marketing and label claims for cosmetics and consumer products
- Gene Sequencing Services: Specialized genomics services including Whole Exome and Whole Genome sequencing, RT-PCR assays, RNA Sequencing
- Biodegradability Testing: Sustainability testing services for ingredients, finished products, packaging materials, and microplastics
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
MS CLINICAL RESEARCH product offering
Product offeringCore offering
MS Clinical Research is a full-service clinical and preclinical research institute that designs and executes safety, efficacy, and claim-substantiation studies for pharmaceutical, cosmetics, personal care, consumer products, and chemical/agrochemical companies. The offering spans GLP-compliant preclinical in vitro toxicology, microbiology, stability, ex vivo skin permeation, and gene sequencing, as well as phases II–IV dermatology and ophthalmology clinical trials, including India's only photobiology SPF/UVAPF testing centre, delivered through a 40-site, 16-country global investigator network.
Product overview
MS Clinical Research (MSCR) is a full-service clinical and preclinical research institute offering 360° testing services for pharmaceuticals, cosmetics, and consumer products. The company operates as a unified platform combining multiple specialized service lines: Clinical Studies (dermatology, ophthalmology), PreClinical Studies (toxicology, in vitro efficacy, microbiology, ex vivo testing), Consumer Care Testing (hair, skin, oral, home, colour cosmetics, baby care), and specialized services (SPF testing, gene sequencing, biodegradability testing, stability testing). MSCR also provides proprietary software tools including eCRF/EDC software and a Compliance App. The company leverages GLP-compliant facilities with MatTek tissue models and operates India's only photobiology testing centre for SPF evaluations.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Studies (Dermatology and Ophthalmology Trials)
- PreClinical Studies GLP-compliant preclinical testing including in vitro toxicology, microbiology, in vitro efficacy, ex vivo skin testing, stability testing, and Franz cell permeation studies using MatTek reconstructed tissue models.
- Consumer Care Testing Comprehensive clinical and preclinical testing services spanning skin care, hair care, oral care, home care, colour cosmetics, and baby care products, including safety, efficacy, and claim substantiation.
- Safety Testing
- SPF Testing SPF and UVAPF in vivo and in vitro evaluations for sunscreen and photoprotection products using Solar Light Multiport 601 and Solar Light 16S solar simulators.
- In Vitro Toxicology Services In vitro toxicology using MatTek 3D human tissue models (EpiDerm, EpiOcular, EpiAirway, EpiOral, EpiIntestinal, EpiVaginal) for skin, eye, respiratory, oral, and vaginal irritation and corrosion testing.
- Microbiology Testing Antimicrobial testing including challenge tests, zone of inhibition, MIC/MBC determination, and preservation efficacy testing per ISO and pharmacopoeia standards.
- Ex Vivo Skin Testing and Franz Cell Testing Skin explant testing for pigmentation, anti-aging, hydration, and permeation studies using Franz cell diffusion apparatus following OECD/OCDE 428 guidelines.
- In Vitro Efficacy Testing In vitro efficacy testing of active ingredients using reconstructed tissue models for dermal drug delivery, skin hydration, wound healing, and UV protection endpoints.
- Stability Testing Accelerated and real-time stability testing for cosmetic products including compatibility testing and Period After Opening (PAO) studies.
- Cytotoxicity Testing In vitro toxicology and safety pharmacology services including skin irritation, corrosion, and EpiOcular eye irritation testing per OECD guidelines.
- Gene Sequencing Services Specialized dermatology-focused gene sequencing including whole exome and whole genome sequencing, RT-PCR assays, and skin, hair, and oral microbiome sequencing, delivered from a NABL-accredited 3,500 sq ft laboratory.
- Global Clinical Trial Services Global clinical trial management across 40+ dermatology sites in 16 countries, providing diverse volunteer access, local regulatory expertise, and technology-based remote monitoring.
- Biodegradability Testing Biodegradability and compostability testing of ingredients, finished products, packaging materials, and microplastics following ASTM, ISO, and OECD standards.
- Dermatology Services Clinical dermatology studies using specialised skin-of-colour evaluation techniques including tape stripping, chamber wash, and skin biopsies.
- Ophthalmology Services Phase I–III ophthalmology clinical trials for conditions including dry eye, glaucoma, cataracts, and contact lens solutions.
- eCRF/EDC Software
- Compliance App
Quantifiable outcome
- 10-day turnaround for study completion
- +3 more outcomes
Companies that use MS CLINICAL RESEARCH
Customer profileSegments4 records
Ideal customer profiles3 records
MS CLINICAL RESEARCH technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
MS CLINICAL RESEARCH partnerships and signals
Strategic signalScale indicators12 records
Recent moves11 records
Expansion highlights6 records
MS CLINICAL RESEARCH competitors and assessment
Company assessmentBroad incumbents
- SGS: Global testing, inspection, and certification company with significant cosmetics, personal care, and life sciences testing capacity. Comparable on the consumer care testing and certification value proposition but operates globally with much broader non-clinical mix.
- Eurofins Scientific: Global testing services group with substantial personal care, cosmetics, and pharmaceutical testing operations. Comparable on testing-led services for cosmetics, pharma, and consumer products but at much larger scale and global reach.
- Intertek: Global quality assurance and testing provider with a meaningful personal care, cosmetics, and consumer products testing franchise. Comparable on consumer product safety/efficacy testing and regulatory compliance services but at much larger global scale.
- IQVIA: World's largest CRO offering full clinical development and laboratory services across all therapeutic areas and geographies. Comparable on clinical trial execution and dermatology exposure but with substantially broader portfolio, data assets, and global footprint.
- Charles River Laboratories: Global CRO with a major safety assessment/preclinical toxicology business serving pharma and consumer products. Comparable on GLP toxicology and safety assessment services but operates at vastly larger scale and broader therapeutic/industrial scope than MSCR.
Direct peers
- Anthem Biosciences: India-based privately held CRO/CDMO providing drug discovery, preclinical, and clinical research services. Comparable as a privately held, India-rooted CRO of similar scale serving pharma and consumer care clients with end-to-end offerings.
- Syngene International: India-based integrated CRO/CDMO offering preclinical safety, clinical trial support, and dermatology/cosmetics testing with global clients. Directly comparable on geographic origin, customer mix (pharma and personal care), and full-service preclinical-to-clinical positioning.
- Reading Scientific Services (RSSL): UK-based contract research and scientific services provider focused on food, personal care, cosmetics, and consumer healthcare testing. Comparable in the personal care/cosmetics claim-substantiation and safety testing niche with a similar mix of regulated and R&D services.
- Lambda Therapeutic Research: India-based full-service clinical CRO running Phase I-IV trials, bioequivalence studies, and clinical operations across multiple therapeutic areas. Comparable as a private India-headquartered CRO serving global pharma sponsors with similar pricing/cost advantages.
- Bioneeds India: India-based preclinical CRO providing GLP toxicology, in vitro toxicology, safety pharmacology, and discovery services. Comparable in India CRO positioning, GLP-aligned safety testing service mix, and biotech/pharma/agrochem customer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
MS CLINICAL RESEARCH social profiles
Digital presenceMS CLINICAL RESEARCH compliance and trust
Trust signalCompliance3 records
MS CLINICAL RESEARCH financial estimates
Financial estimateRevenue estimate
Valuation estimate
MS CLINICAL RESEARCH leadership team
Management profileNumber of profiles
Profiles10 records
MS CLINICAL RESEARCH subsidiaries and ownership
Company hierarchySubsidiaries2 records
MS CLINICAL RESEARCH funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MS CLINICAL RESEARCH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MS CLINICAL RESEARCH
What does MS CLINICAL RESEARCH do?
MS Clinical Research is a full-service clinical and preclinical research institute that designs and executes safety, efficacy, and claim-substantiation studies for pharmaceutical, cosmetics, personal care, consumer products, and chemical/agrochemical companies. The offering spans GLP-compliant preclinical in vitro toxicology, microbiology, stability, ex vivo skin permeation, and gene sequencing, as well as phases II–IV dermatology and ophthalmology clinical trials, including India's only photobiology SPF/UVAPF testing centre, delivered through a 40-site, 16-country global investigator network.
Is MS CLINICAL RESEARCH a public or private company?
MS CLINICAL RESEARCH is a private company. It is classified as family owned and is currently operating.
When was MS CLINICAL RESEARCH founded?
MS CLINICAL RESEARCH was founded in 2009. It employs 101 to 250 people.
Where is MS CLINICAL RESEARCH based?
MS CLINICAL RESEARCH is headquartered in Bangalore, India, in the Asia region.
How does MS CLINICAL RESEARCH make money?
Six revenue lines are on record. Clinical Trials Services are the primary driver. The others are preclinical Testing Services, safety Testing Services, claim Substantiation Studies, gene Sequencing Services and biodegradability Testing.
Who are MS CLINICAL RESEARCH's main competitors?
Broad incumbents on record are SGS, Eurofins Scientific, Intertek, IQVIA and Charles River Laboratories. Direct peers are Anthem Biosciences, Syngene International, Reading Scientific Services (RSSL), Lambda Therapeutic Research and Bioneeds India.
Does MS CLINICAL RESEARCH have an API?
No public API is recorded for MS CLINICAL RESEARCH.
What industry is MS CLINICAL RESEARCH in?
MS CLINICAL RESEARCH's product category is Contract Research Organization (Clinical and Preclinical Research Services). Its primary akta.pro industry code is HLAGAAAC, Toxicology & Safety Assessment CROs (GLP), with a secondary code of HLAGAFAD, GLP Toxicology (Repeat-Dose, Acute/Subacute). Its NAICS code is 5417 and its SIC code is 8731.